Virax Biolabs Group Ltd

VRAX · XNAS

CIK 1885827fmd_1E7EZG81W952JV1AC4G50H6GM8Manufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Apr 01, 2020 to Mar 31, 2026, 6 periods

Ratios computed from the standardized statements. Select a value to open its proof.